Current Opinion in Pharmacology · Oct 27, 2026

Clinical application progress of neural stem cells

By Dai L, Chen SX, Yang ZC

Neural stem cells (NSCs) possess self-renewal capacity and multipotent differentiation potential. While endogenous NSC function declines in neurodegenerative diseases, exogenous NSC transplantation exhibits therapeutic efficacy against brain disorders, such as Alzheimer's, Parkinson's, stroke, and traumatic brain injury, via cell replacement, promoting neurotrophic factor secretion, and immunomodulation. Furthermore, combining NSCs with nanoparticles or traditional medicines enhances therapeutic outcomes, while their inherent tumor tropism enables targeted anticancer drug delivery. However, clinical translation faces significant hurdles, including safety risks (tumorigenicity and immune rejection), sourcing constraints, ethical concerns, and microenvironmental sensitivity. Optimizing cryopreservation technology to establish high-quality NSC banks and constructing sound regulatory frameworks represent critical solutions. This review systematically summarizes the therapeutic mechanisms, clinical progress, and translational barriers of NSC-based therapies. Moving forward, accelerating clinical translation requires elucidating underlying mechanisms, optimizing isolation, culture, and preservation protocols, strengthening safety evaluations, and refining regulatory governance.

doi.org/10.1016/j.coph.2026.102683PubMed 43019701Interventions

AgingResearch.News